Approval · Notice of Compliance 10217 · 2009
TYKERB: Notice of Compliance 10217
Issued May 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10217
- Date
- May 15, 2009
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYKERB | 02326442 | Marketed |
Medicinal ingredients
- LAPATINIB DITOSYLATE MONOHYDRATE 250 MG per TAB